OrbusNeich Medical Group Holdings (FRA:Q8T) Operating Margin %: 24.43% (As of Dec. 2025) — 38% Above Median


FRA:Q8T OrbusNeich Medical Group Holdings Ltd FRA:Q8T
95 GF Score
Price €0.38
GF Value €0.49
! 2 Warning Signs
View Full Analysis

What is OrbusNeich Medical Group Holdings Operating Margin %?

OrbusNeich Medical Group Holdings FRA:Q8T +1.07% 95 Operating Margin % is 24.43% as of Dec. 2025, which is 38% above its 10-year median of 17.64. GuruFocus rates FRA:Q8T with a GF Score™ of 95/100 and a GF Value™ of €0.49. The stock has 2 warning signs investors should review. Among 816 Medical Devices & Instruments companies, OrbusNeich Medical Group Holdings ranks better than 89.71% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. OrbusNeich Medical Group Holdings's Operating Income for the six months ended in Dec. 2025 was €20.2 Mil. OrbusNeich Medical Group Holdings's Revenue for the six months ended in Dec. 2025 was €82.8 Mil. Therefore, OrbusNeich Medical Group Holdings's Operating Margin % for the quarter that ended in Dec. 2025 was 24.43%.

Good Sign:

OrbusNeich Medical Group Holdings Ltd operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for OrbusNeich Medical Group Holdings's Operating Margin % or its related term are showing as below:

FRA:Q8T' s Operating Margin % Range Over the Past 10 Years
Min: 7.75   Med: 17.64   Max: 25.61
Current: 22.13


FRA:Q8T's Operating Margin % is ranked better than
89.71% of 816 companies
in the Medical Devices & Instruments industry
Industry Median: 3.465 vs FRA:Q8T: 22.13

OrbusNeich Medical Group Holdings's 5-Year Average Operating Margin % Growth Rate was 19.50% per year.

OrbusNeich Medical Group Holdings's Operating Income for the six months ended in Dec. 2025 was €20.2 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was €34.3 Mil.


OrbusNeich Medical Group Holdings  (FRA:Q8T) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


OrbusNeich Medical Group Holdings Operating Margin % Related Terms


OrbusNeich Medical Group Holdings Operating Margin % Historical Data

* Premium members only.

The historical data trend for OrbusNeich Medical Group Holdings's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OrbusNeich Medical Group Holdings Operating Margin % Chart

OrbusNeich Medical Group Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial 17.47 17.64 25.61 21.42 22.14

OrbusNeich Medical Group Holdings Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.31 21.71 21.15 19.49 24.43

FRA:Q8T vs ISRG, BDX, MDLN: Operating Margin % Comparison

For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrbusNeich Medical Group Holdings Operating Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's Operating Margin % distribution charts can be found below:

* The bar in red indicates where OrbusNeich Medical Group Holdings's Operating Margin % falls into.


FRA:Q8T
95GF Score
OrbusNeich Medical Group Holdings Ltd FRA:Q8T
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OrbusNeich Medical Group Holdings Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

OrbusNeich Medical Group Holdings's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=34.12 / 154.108
=22.14 %

OrbusNeich Medical Group Holdings's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=20.214 / 82.756
=24.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 24.43% mean?
OrbusNeich Medical Group Holdings (FRA:Q8T) has a Operating Margin % of 24.43% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on OrbusNeich Medical Group Holdings and its competitors. This is 38% above median its historical median of 17.64. Over the past decade, OrbusNeich Medical Group Holdings' Operating Margin % has ranged from 7.75 to 25.61. According to the industry distribution chart, OrbusNeich Medical Group Holdings ranks #84 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 10.3%.
Is OrbusNeich Medical Group Holdings' Operating Margin % too high?
OrbusNeich Medical Group Holdings' current Operating Margin % of 24.43% is 38% above median its 10-year median of 17.64. Over the past 10 years, this metric has ranged from a low of 7.75 to a high of 25.61. The Medical Devices & Instruments industry median Operating Margin % is 3.47. OrbusNeich Medical Group Holdings' value of 24.43% is 605.1% above this industry median. Based on the distribution chart, OrbusNeich Medical Group Holdings ranks #84 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, OrbusNeich Medical Group Holdings has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does OrbusNeich Medical Group Holdings' Operating Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, OrbusNeich Medical Group Holdings ranks #84 out of 816 companies for Operating Margin %. This places OrbusNeich Medical Group Holdings in the top 10% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 3.47. OrbusNeich Medical Group Holdings' value of 24.43% is 605.1% above this benchmark. Historically, OrbusNeich Medical Group Holdings' own Operating Margin % has ranged from 7.75 to 25.61 over the past decade. While the company's 10-year median is 17.64 vs. the industry median of 3.47, OrbusNeich Medical Group Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.47, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OrbusNeich Medical Group Holdings's current Operating Margin % of 24.43% is 605.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on OrbusNeich Medical Group Holdings and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OrbusNeich Medical Group Holdings's current Operating Margin % is 24.43%, which is 38% above median its own 10-year median of 17.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrbusNeich Medical Group Holdings stock overvalued right now?
OrbusNeich Medical Group Holdings (FRA:Q8T) has a current Operating Margin % of 24.43%. The stock's GF Value™ is €0.49, compared to a current price of €0.38 — trading 22.9% below its estimated fair value. The current Operating Margin % is 24.43%, which is 38% above median its 10-year median of 17.64 and 605.1% above the Medical Devices & Instruments industry median of 3.47. OrbusNeich Medical Group Holdings' overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For OrbusNeich Medical Group Holdings (FRA:Q8T), the current Operating Margin % is 24.43% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OrbusNeich Medical Group Holdings (FRA:Q8T) Overvalued in 2026?

Based on GuruFocus' analysis, OrbusNeich Medical Group Holdings stock appears to be undervalued. The current stock price of €0.38 is trading 22.9% below its estimated GF Value™ of €0.49.

Key valuation signals for FRA:Q8T:

  • Operating Margin %: 24.43% (38% above median its 10-year median of 17.64)
  • GF Value™: €0.49 vs. price of €0.38 (22.9% below fair value)
  • GF Score™: 95/100 with 2 warning signs
  • Industry Position: 605.1% above the Medical Devices & Instruments median (#84 of 816)

No single metric tells the full story. See the FRA:Q8T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


OrbusNeich Medical Group Holdings Business Description

Other Exchanges 06929:Hong Kong
Address 3rd Floor, Building 20E, Units 303 and 305, Hong Kong Science Park, Shatin New Town, Hong Kong, HKG
OrbusNeich Medical Group Holdings Ltd is an investment holding company. The Company principally engaged in the manufacturing, trading, sales and marketing of medical devices/instruments used for the treatment of coronary and peripheral vascular diseases. The group has only one operating segment. The company has presence in APAC, EMEA, Japan, United States, The PRC, and Others of which majority of revenue comes from APAC.
95GF Score

Get the complete analysis for FRA:Q8T

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.38
Price
€0.49
GF Value